The Acute Kidney Injury (AKI) Disease Treatment market was valued at US$29.612 billion in 2019 and is expected to grow at a CAGR of 1.09% over the forecast period to reach a market size of US$31.600 billion in 2025. Rising wellbeing awareness among people, particularly in the developing nations will prompt frequent check-ups, radiating the acute kidney injury disease treatment market development attributable to early disease detection followed by treatment during the estimated time frame and past.